2019–2020 Drug Updates in Hematologic Malignancies
Presented by Heidi D. Finnes, PharmD, BCOP, FHOPA
From Mayo Clinic, Rochester, Minnesota
J Adv Pract Oncol 2021;12(3):279–283 |
© 2021 Harborside™
During JADPRO Live Virtual 2020, Heidi D. Finnes, PharmD, BCOP, FHOPA, discussed the pharmacology and indications of medications approved from late 2019 to late 2020 for the management of patients with hematologic malignancies, reviewed pivotal clinical trial data, and covered the adverse events of these hematologic medications.
For access to the full length article, please sign in